Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ...

被引:141
作者
Baron, Eric P. [1 ]
机构
[1] Cleveland Clin Neurol Inst, Dept Neurol, Ctr Headache & Pain, 10524 Euclid Ave,C15-23, Cleveland, OH 44195 USA
来源
HEADACHE | 2015年 / 55卷 / 06期
关键词
cannabis; hemp; headache; medical marijuana; cannabinoids; cannabidiol; CBD; delta-9-tetrahydrocannabinol; THC; CHEMOTHERAPY-INDUCED NAUSEA; GLUTAMATERGIC SYNAPTIC-TRANSMISSION; ENDOCANNABINOID DEFICIENCY CECD; RANDOMIZED CONTROLLED-TRIAL; IRRITABLE-BOWEL-SYNDROME; CENTRAL NEUROPATHIC PAIN; RAT HIPPOCAMPAL-NEURONS; MULTIPLE-SCLEROSIS CAMS; CHRONIC NONCANCER PAIN; BREAST-CANCER CELLS;
D O I
10.1111/head.12570
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background.-The use of cannabis, or marijuana, for medicinal purposes is deeply rooted though history, dating back to ancient times. It once held a prominent position in the history of medicine, recommended by many eminent physicians for numerous diseases, particularly headache and migraine. Through the decades, this plant has taken a fascinating journey from a legal and frequently prescribed status to illegal, driven by political and social factors rather than by science. However, with an abundance of growing support for its multitude of medicinal uses, the misguided stigma of cannabis is fading, and there has been a dramatic push for legalizing medicinal cannabis and research. Almost half of the United States has now legalized medicinal cannabis, several states have legalized recreational use, and others have legalized cannabidiol-only use, which is one of many therapeutic cannabinoids extracted from cannabis. Physicians need to be educated on the history, pharmacology, clinical indications, and proper clinical use of cannabis, as patients will inevitably inquire about it for many diseases, including chronic pain and headache disorders for which there is some intriguing supportive evidence. Objective.-To review the history of medicinal cannabis use, discuss the pharmacology and physiology of the endocannabinoid system and cannabis-derived cannabinoids, perform a comprehensive literature review of the clinical uses of medicinal cannabis and cannabinoids with a focus on migraine and other headache disorders, and outline general clinical practice guidelines. Conclusion.-The literature suggests that the medicinal use of cannabis may have a therapeutic role for a multitude of diseases, particularly chronic pain disorders including headache. Supporting literature suggests a role for medicinal cannabis and cannabinoids in several types of headache disorders including migraine and cluster headache, although it is primarily limited to case based, anecdotal, or laboratory-based scientific research. Cannabis contains an extensive number of pharmacological and biochemical compounds, of which only a minority are understood, so many potential therapeutic uses likely remain undiscovered. Cannabinoids appear to modulate and interact at many pathways inherent to migraine, triptan mechanisms of action, and opiate pathways, suggesting potential synergistic or similar benefits. Modulation of the endocannabinoid system through agonism or antagonism of its receptors, targeting its metabolic pathways, or combining cannabinoids with other analgesics for synergistic effects, may provide the foundation for many new classes of medications. Despite the limited evidence and research suggesting a role for cannabis and cannabinoids in some headache disorders, randomized clinical trials are lacking and necessary for confirmation and further evaluation.
引用
收藏
页码:885 / 916
页数:32
相关论文
共 698 条
[1]   EFFECT OF ORAL-ADMINISTRATION OF DELTA-9-TETRAHYDROCANNABINOL ON AIRWAY MECHANICS IN NORMAL AND ASTHMATIC SUBJECTS [J].
ABBOUD, RT ;
SANDERS, HD .
CHEST, 1976, 70 (04) :480-485
[2]   EFFECTS OF MARIHUANA ON SOLUTION OF ANAGRAMS, MEMORY AND APPETITE [J].
ABEL, EL .
NATURE, 1971, 231 (5300) :260-&
[3]   AN EFFICIENT NEW CANNABINOID ANTIEMETIC IN PEDIATRIC ONCOLOGY [J].
ABRAHAMOV, A ;
ABRAHAMOV, A ;
MECHOULAM, R .
LIFE SCIENCES, 1995, 56 (23-24) :2097-2102
[4]  
Abramovici H., 2013, Information for health care professionals: Cannabis (marihuana, marijuana) and the cannabinoids
[5]   Vaporization as a smokeless cannabis delivery system: A pilot study [J].
Abrams, D. I. ;
Vizoso, H. P. ;
Shade, S. B. ;
Jay, C. ;
Kelly, M. E. ;
Benowitz, N. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) :572-578
[6]   Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial [J].
Abrams, D. I. ;
Jay, C. A. ;
Shade, S. B. ;
Vizoso, H. ;
Reda, H. ;
Press, S. ;
Kelly, M. E. ;
Rowbotham, M. C. ;
Petersen, K. L. .
NEUROLOGY, 2007, 68 (07) :515-521
[7]   Cannabinoid-Opioid Interaction in Chronic Pain [J].
Abrams, D. I. ;
Couey, P. ;
Shade, S. B. ;
Kelly, M. E. ;
Benowitz, N. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (06) :844-851
[8]  
Abrams DI, 2000, INT C AIDS, V13, P45
[9]   Anticancer activity of anandamide in human cutaneous melanoma cells [J].
Adinolfi, Barbara ;
Romanini, Antonella ;
Vanni, Alessia ;
Martinotti, Enrica ;
Chicca, Andrea ;
Fogli, Stefano ;
Nieri, Paola .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 718 (1-3) :154-159
[10]   Cannabinergic Pain Medicine A Concise Clinical Primer and Survey of Randomized-controlled Trial Results [J].
Aggarwal, Sunil K. .
CLINICAL JOURNAL OF PAIN, 2013, 29 (02) :162-171